fluorouracil has been researched along with Gangrene in 2 studies
Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.
Gangrene: Death and putrefaction of tissue usually due to a loss of blood supply.
Excerpt | Relevance | Reference |
---|---|---|
"Celecoxib dosage was fixed." | 2.75 | A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer. ( Alqaisi, M; Bernal, P; Bush, D; Byrd, J; Garberoglio, C; Hussein, F; Malik, I, 2010) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Malik, I | 1 |
Hussein, F | 1 |
Bush, D | 1 |
Alqaisi, M | 1 |
Bernal, P | 1 |
Byrd, J | 1 |
Garberoglio, C | 1 |
Zilling, TL | 1 |
Ahrén, B | 1 |
1 trial available for fluorouracil and Gangrene
Article | Year |
---|---|
A phase I study of capecitabine, irinotecan, celecoxib, and radiation as neoadjuvant therapy of patients with locally advanced rectal cancer.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Capecitab | 2010 |
1 other study available for fluorouracil and Gangrene
Article | Year |
---|---|
Ischaemic pancolitis: a serious complication of chemotherapy in a previously irradiated patient. Case report.
Topics: Carcinoma, Squamous Cell; Cisplatin; Colitis; Combined Modality Therapy; Dysgerminoma; Esophageal Ne | 1989 |